- Home
- WKHS vs SCNX Comparison
WKHS vs SCNX Comparison
Compare WKHS & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WKHS | SCNX |
|---|---|---|
| Founded | 2007 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.7M | 16.2M |
| IPO Year | 2008 | 2019 |
Fundamental Metrics
Financial Performance| Metric | WKHS | SCNX |
|---|---|---|
| Price | $2.86 | $0.31 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $21.00 | $1.50 |
| AVG Volume (30 Days) | 89.1K | ★ 294.3K |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 86.92 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $763,173.00 | ★ $3,831,778.00 |
| Revenue This Year | $89.23 | $1,097.38 |
| Revenue Next Year | $28.84 | $239.80 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 30.72 |
| 52 Week Low | $0.53 | $0.24 |
| 52 Week High | $11.80 | $2.60 |
Technical Indicators
Market Signals| Indicator | WKHS | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 43.31 | 31.79 |
| Support Level | $2.84 | $0.30 |
| Resistance Level | $3.51 | $0.43 |
| Average True Range (ATR) | 0.23 | 0.02 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 2.60 | 10.60 |
Price Performance
Historical ComparisonAbout WKHS Workhorse Group Inc.
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric vehicles, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.